tiprankstipranks
Kaleido Biosciences (KLDO)
:KLDO
US Market

Kaleido Biosciences (KLDO) Income Statement

Compare
197 Followers

Kaleido Biosciences Income Statement

Last quarter (Q3 2023), Kaleido Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kaleido Biosciences's net income was $0.00. See Kaleido Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 1.10M$ 975.00K$ 0.00$ 0.00
Gross Profit
$ 0.00$ -1.25M$ 919.03K$ -1.32M$ 0.00
Operating Expenses
$ 0.00$ 88.77M$ 79.85M$ 86.66M$ 60.68M
Depreciation and Amortization
$ 228.49K$ 2.58M$ 1.82M$ 1.32M$ 792.00K
EBITDA
$ 0.00$ -85.09M$ -77.00M$ -86.66M$ -59.03M
Operating Income
$ 0.00$ -87.67M$ -78.87M$ -86.66M$ -60.68M
Other Income/Expenses
$ 0.00$ -2.62M$ -2.75M$ 329.00K$ -1.06M
Pretax Income
$ 0.00$ -90.29M$ -81.62M$ -86.33M$ -61.74M
Net Income
$ 0.00$ -93.27M$ -79.80M$ -85.01M$ -61.74M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ -2.23$ -2.39$ -3.31$ -2.10
Diluted EPS
$ 0.00$ -2.23$ -2.39$ -3.31$ -2.10
Weighted Average Shares Outstanding
0.00 41.86M 33.45M 25.70M 29.39M
Weighted Average Shares Outstanding (Diluted)
0.00 41.86M 33.45M 25.70M 29.39M
Currency in USD

Kaleido Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis